Sfoglia per AUTORE
PEYVANDI F
Collezione AOU Novara
Items : 3
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study. in Blood / Blood. 2025 Mar 7:blood.2024027008. doi: 10.1182/blood.2024027008.
2025
AOU Novara
AOU Novara
Young G; Kavakli K; Klamroth R; Matsushita T; Peyvandi F; Pipe SW MD; Rangarajan S; Shen MC; Srivastava A; Sun J; Tran HA; You CW; Zülfikar BB; Menapace LA; Zhang C; Shen Y; Puurunen M; Demissie M; Kenet G;
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients. in Microorganisms / Microorganisms. 2022 Jun 10;10(6):1191. doi: 10.3390/microorganisms10061191.
2022
AOU Novara
AOU Novara
Cugno M; Meroni PL; Consonni D; Griffini S; Grovetti E; Novembrino C; Torri A; Griffante G; Gariglio M; Varani L; Peyvandi F;
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. in Journal of autoimmunity / J Autoimmun. 2021 Nov;124:102728. doi: 10.1016/j.jaut.2021.102728. Epub 2021 Sep 27.
2021
AOU Novara
AOU Novara
Cugno M; Macor P; Giordano M; Manfredi M; Griffini S; Grovetti E; De Maso L; Mellone S; Valenti L; Prati D; Bonato S; Comi G; Artoni A; Meroni PL; Peyvandi F;